On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...